Oral selective estrogen receptor degraders (SERDs): The new emperors in breast cancer clinical practice?
Semin Oncol
; 50(3-5): 90-101, 2023.
Article
in En
| MEDLINE
| ID: mdl-37673696
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Language:
En
Journal:
Semin Oncol
Year:
2023
Document type:
Article
Country of publication: